The ebb and flow of such autoimmune diseases as multiple sclerosis, lupus and rheumatoid arthritis has long been a perplexing mystery to scientists. But new findings from the Stanford University School of Medicine bring scientists closer to solving the puzzle, identifying a molecule that appears to play a central role in these relapses.
In Vancouver, BC private clinic opens despite warnings. Vancouver’s False Creek Urgent Care Centre promises to work within public health system of Canada. The False Creek Urgent Care Centre was founded by Dr. Mark Godley, medical director of the False Creek Surgical Centre.
Surveillance for the HIV virus is weak in most of the world and prevention and treatment programmes often fail to reach high-risk drug users, homosexuals and sex workers, the World Health Organisation said.
After twenty years’ experience and hundreds of conferences and seminars, it is time to move beyond the endlessly repeated statistics, and to face the AIDS challenge head-on with effective specific solutions. We know what must be done to prevent further infection, expand care, treatment, and support, and reduce stigma and discrimination.
Universal treatment by 2010 is the promise. It must be kept.
Political leaders are gradually becoming more aware of the need for food and nutritional support in the ‘essential package of care’ for people affected by HIV.
Physicians who once treated mainly elderly patients for health problems such as diabetes, heart disease and stroke are seeing increasingly younger patients who have the same ailments.
A team of Vanderbilt and University of Dundee scientists envisions a future when computer simulations will be used to predict a tumor’s clinical progression and formulate individualized treatment plans. The group has developed a mathematical model for cancer invasion powerful enough for this purpose. The result was published as an entirely theoretical paper in the journal Cell and represents a “sea change” in how biology is done.
The first human trial of gene transfer therapy for erectile dysfunction (ED) indicates that gene therapy that lasts for months and eliminates the patient’s need for on-demand drugs (such as Viagra and Cialis), could become the future treatment of choice for this common problem, according to a paper in the most recent issue of Human Gene Therapy.
Brain cells derived from human embryonic stem cells improved the condition of rats with Parkinson’s-like symptoms dramatically, but the treatment caused a significant problem — the appearance of brain tumors — that scientists are now working to solve. The study is featured on the cover of the November issue of Nature Medicine.